Malignant upper urinary tract obstruction in cancer patients: A systematic review

Max Shah; Francesca Blest; James Blackmur; Alexander Laird; Shoba Dawson; Jonathan Aning

doi:10.1002/bco2.340

journal article Open Access Feb 27, 2024

Malignant upper urinary tract obstruction in cancer patients: A systematic review

Max Shah Francesca Blest James Blackmur

Alexander Laird

Shoba Dawson

Jonathan Aning

BJUI Compass Vol. 5 No. 5 pp. 519-530 · Wiley

View at Publisher Save 10.1002/bco2.340

Abstract

AbstractObjectiveTo systematically summarise the current clinical evidence for de novo malignant upper urinary tract obstruction treatment with a focus on standards of reporting, patient outcomes and future research needs.MethodsThis review protocol was published via PROSPERO (CRD42022341588). OVID MEDLINE (R), EMBASE, Cochrane Central Register of Controlled Trials—CENTRAL were searched up to June 2022 in accordance with the Preferred Reporting Items for Systematic Reviews and Meta‐analyses. Prospective and retrospective studies were included.ResultsOf 941 articles identified, 82 with 8796 patients were eligible for inclusion.Most studies in the published literature are retrospective and investigate heterogenous malignancies. Percutaneous nephrostomy and ureteric stenting are the most studied interventions. Few studies describe the outcomes from no intervention or investigate patient perspectives. Overall reported median survival after intervention was around 11.7 months. A lack of standardised reporting of outcomes was evident.ConclusionsMalignant upper urinary tract obstruction is an important clinical condition affecting patients globally. Overall survival after intervention appears poor however the current evidence base has significant limitations due to studies of low methodological quality and the lack of a standardised framework for reporting outcomes.We have provided a pragmatic framework for future studies based on the review to ensure a uniform methodology is utilised moving forward.

Topics

No keywords indexed for this article. Browse by subject →

References

90

[1]

10.48083/10.48083/aykf2124

[2]

10.1038/s41598-021-86136-y

[3]

10.3390/jcm10112354

[4]

10.5812/ijcm.6074

[5]

10.3348/kjr.2018.19.4.606

[6]

Mason JB "Prognostic factors for overall survival in malignant ureteral obstruction" Can J Urol (2022)

[7]

10.1007/s00520-012-1666-6

[8]

10.1089/089277901753205834

[9]

10.3969/j.issn.1674-8115.2015.12.032

[10]

10.1097/00005392-199707000-00014

[11]

10.1259/bjr/38306763

[12]

Liaw CC "Gastric cancer with obstructive uropathy: clinical experience with 17 cases" Changgeng Yi Xue Za Zhi (1997)

[13]

Plesinac K "Percutaneous nephrostomy in the management of advanced and terminal‐stage gynecologic malignancies: outcome and complications" Eur J Gynaecol Oncol (2010)

[14]

10.4103/ijc.ijc_704_18

[15]

10.1590/s1677-55382006000300004

[16]

10.1016/j.juro.2010.09.102

[17]

10.1016/j.jpainsymman.2015.09.009

[18]

10.1371/journal.pone.0184965

[19]

10.1089/end.2021.0364

[20]

10.1089/end.2017.29029.abstracts

[21]

10.1111/j.1464-410x.1995.tb07841.x

[22]

10.1016/j.urology.2021.09.007

[23]

10.1097/igc.0b013e318243b475

[24]

10.1111/j.1442-2042.2007.01747.x

[25]

10.1016/j.ejogrb.2019.08.020

[26]

10.1016/j.juro.2007.03.026

[27]

10.1007/s00520-020-05662-z

[28]

10.1016/0090-4295(91)80198-g

[29]

10.1111/j.1464-410x.2007.07172.x

[30]

10.1111/j.1464-410x.2009.08492.x

[31]

10.1111/j.1464-410x.1980.tb08909.x

[32]

10.1186/s12957-019-1608-6

[33]

10.1186/s12894-019-0569-y

[34]

10.1111/j.1447-0756.2010.01486.x

[35]

10.1016/s0022-5347(17)56643-4

[36]

10.1111/j.1464-410x.1993.tb15995.x

[37]

10.1308/1478708051432

[38]

10.1016/j.juro.2008.04.011

[39]

10.1080/09699260.2021.1905145

[40]

10.1016/j.clgc.2013.04.030

[41]

10.1111/iju.13500

[42]

10.2147/cmar.s172283

[43]

Barton DP "Percutaneous nephrostomy and ureteral stenting in gynecologic malignancies" Obstet Gynecol (1992)

[44]

Bordinazzo R "Ureteral obstruction associated with prostate cancer: the outcome after ultrasonographic percutaneous nephrostomy" Arch Ital Urol Androl (1994)

[45]

10.1016/s0022-5347(17)59536-1

[46]

10.1259/0007-1285-64-760-318

[47]

Chefchaouni MC "Endoscopic ureteroneocystostomy: palliative urinary diversion in advanced prostatic cancer" Tech Urol (1998)

[48]

10.1590/1806-9282.62.03.255

[49]

10.1007/bf02305670

[50]

10.1089/end.2013.0281

Showing 50 of 90 references

Metrics

8

Citations

90

References

Details

Published: Feb 27, 2024
Vol/Issue: 5(5)
Pages: 519-530
License: View

Authors

M

Max Shah

University of Bristol Bristol UK

F

Francesca Blest

University of Bristol Bristol UK

J

James Blackmur

Department of Urology Cambridge University Hospitals NHS Foundation Trust Cambridge UK; Early Cancer Institute University of Cambridge Cambridge UK

A

Alexander Laird

Department of Urology, Western General Hospital Edinburgh UK; Institute of Genetics and Cancer The University of Edinburgh Edinburgh UK

S

Shoba Dawson

University of Bristol Bristol UK

J

Jonathan Aning

Bristol Urological Institute, Southmead Hospital North Bristol Trust Bristol UK; Population Health Sciences, Bristol Medical School University of Bristol Bristol UK

Cite This Article

Max Shah, Francesca Blest, James Blackmur, et al. (2024). Malignant upper urinary tract obstruction in cancer patients: A systematic review. BJUI Compass, 5(5), 519-530. https://doi.org/10.1002/bco2.340

Malignant upper urinary tract obstruction in cancer patients: A systematic review

You May Also Like